Fat: bariatric surgery and procedures

Hopkins KD, Lehmann ED. Successful medical treatment of obesity in 10th century Spain. Lancet 1995;346:452. https://doi.org/10.1016/S0140- 6736(95)92830-8

Leyton O. A note on the effect of gastro-jejunostomy upon a case of mild diabetes mellitus with a low renal threshold. Lancet 1925;206:1162-63. https://doi.org/10.1016/S0140-6736(01)50045-8

Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nu- tritional importance of proximal and distal small intestine. Ann Surg 1954;140:439-48. https://doi.org/10.1097/00000658-195409000-00018

Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1954;222:339-50. https://doi.org/10.1097/ 00000658-195509000-00011

Rubino F, Marescaux J. Effect of duodenal-jejunal excision in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1-11. https://doi.org/10.1097/01.sla.000002989.54824.fc

Schouten R, Rijs CS, Bouvy ND, et al. A multicentre, randomised efficacy study of the Endo Barrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010;251:236-43. https://doi.org/10.1097/SLA.Ob013e3181bdfbff

Ryder REJ, Irwin SP, Burbridge WTN, et al. The UK’s first NHS Endo barrier service for advanced diabesity: 1-year outcomes for all 62 treated patients. Br J Diabetes 2019; 19: 110-17. https://doi.org/10.10.15277/bjd2019.226

van Baar ACG, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one-year results from the first international, open-label, prospective, multicentre study. Gut 2020;69(2):295-303. https://doi.org/10.1136/gutjnl-2019-318349

Yu J, Zhou X, Li L, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomised and non- randomised evidence. Obes Surg 2015;25(1):143-58. https://doi.org/ 10.1007/S11695-014-1460-2

Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes mellitus; a joint statement by international diabetes organisations. Diabetes Care 2016;39(6):861-77. https://doi.org/10.2337/dc16-0236

Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med Mar 2013;273(3):219-34. https://doi.org/10.1111/joim.12012

Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide, peptide YY, hunger and satiety after gastric bypass surgery in morbidly obese subjects. JCEM 2006;5:1735-40. https://doi.org/10.1210/jc.2005-0904

Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux0en- Y gastric bypass in promoting weight loss and improved glycaemic control. Endocrinology 2012;153:3613-19. https://doi.org/10.1210/en.2011-2145

Sjöholm K, Pajunen P, Jacobson P, et al. Incidence and remission of type 2 diabetes mellitus in relation to degree of obesity at baseline and two year weight change: the Swedish Obese Subjects (SOS) study. Diabetologia 2015;58:1448-53. https://doi.org/10.1007/S00125-015-3591-y

Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term recovery of type 2 diabetes mellitus and with microvascular and macrovascular complications. JAMA 2014;311(22):2297-2304. https://doi.org/10.1001/jama.2014.5988

Madsen LR, Baggesen LM, Richelsen B, Thomsen RW. Effect of Roux-en-T gastric bypass surgery on diabetes mellitus remission and complications in individuals with type 2 diabetes mellitus: a Danish population-based matched cohort study. Diabetologia 2019;62:611-20. https://doi.org/ 10.1007/s00125-019-4816-2

Kermansaravi M, Valizadeh R, Jazi AD, et al. Current status of metabolic/bariatric surgery in type 1 diabetes mellitus: an updated system- atic review and meta-analysis. Obes Surg 2022;32(5):1726-33. https://doi.org/10.1007/s11695-022-05980-7

Lassailly G, Caiazzo R, Ntandja-Qandji L-C, et al. Bariatric surgery provides long-term resolution of non-alcoholic steatohepatitis and regression of fibrosis. Gastroenterology 2020;4:1290-1301. https://doi.org/10.1053/j.gastro.2020.06.006

Aminian A, Zajichek A, Arterburn DE, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type

diabetes mellitus and obesity. JAMA 2019;322(13):1271-82. https://doi.org/10.1001/jama.2019.14231

Syn L, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a 1- stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet 2021;15;397(10287):1830-1841. https://doi.org/10.1016/S0140-6736(21)00591-2

Aminian A, Tu C, Milinovitch A, et al. Association of weight loss achieved through metabolic surgery with risk and severity of Covid-19 infection. JAMA Surg 2022;157(3):221-30. https://doi.org/10.1001/jamasurg.2021.6496

Aminian A, Brethauer SA, Kitwan JP, et al. How safe is metabolic/diabetes surgery? Diabetes Obes Metab 2015;17:198-201. https://doi.org/ 10.1111/dom.12405